Vancouver, British Columbia–(Newsfile Corp. – March 14, 2025) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (“Entheon” or the “Company”) announces that, further to its news release dated January 24, 2025, 1000141080 Ontario Ltd. (“Mentis AI”) has terminated the letter of intent (“LOI”) dated January 23, 2025 which …
Read More »